Hydrogel-based scaffolds for enclosing encapsulated therapeutic cells

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Drug Delivery Systems

Background:

• Cell encapsulation using alginate-poly-L-lysine-alginate (APA) microcapsules is a key technology for therapeutic protein delivery.
• Challenges remain in improving cell retention, reducing post-transplant inflammation, and minimizing fibrotic overgrowth around microcapsules.

Purpose of the Study:

• To develop and analyze novel hydrogel-based scaffolds for enhanced retention and reduced inflammation of erythropoietin (Epo)-secreting cell-loaded microcapsules.
• To evaluate the efficacy of these scaffolds in both in vitro and in vivo models.

Main Methods:

• Development of two types of hydrogel-based scaffolds (preformed and in situ forming) for encapsulating APA microcapsules.
• In vitro assessment of cell viability and protein expression within the scaffolds.
• In vivo implantation of cell-loaded microcapsules within hydrogel scaffolds in mice, followed by hematocrit monitoring and histological analysis.

Main Results:

• In vitro studies confirmed excellent cell viability and protein expression within the hydrogel scaffolds.
• In vivo studies demonstrated sustained hematocrit levels (up to 80% for 2 months) in mice receiving Epo-secreting cell-loaded microcapsules within scaffolds.
• Histological analysis revealed a significant reduction in pericapsular fibrotic overgrowth around microcapsules embedded in hydrogel scaffolds.

Conclusions:

• Hydrogel-based scaffolds effectively improve the administration and retention of microencapsulated cells for therapeutic protein delivery.
• These scaffolds mitigate post-transplantation inflammation and fibrotic reactions, enhancing the biocompatibility of cell encapsulation systems.
• The findings suggest a promising strategy for advancing cell-based therapies requiring sustained protein release.